Latest Announcements

Unicommerce eSolutions Ltd has partnered with Kenstar, a leading home appliance brand, to power e-commerce growth. Kenstar will use Unicommerce's Uniware platform to streamline its e-commerce operations, improve inventory visibility, and enhance warehouse efficiency.

Dr. Agarwal's Eye Hospital Ltd has fixed November 18, 2026 as the record date for determining eligible shareholders to receive consideration shares in the amalgamation with Dr. Agarwal's Health Care Ltd.

Dr. Agarwal's Eye Hospital Ltd has announced the outcome of its board meeting, where it has approved the effectiveness of the scheme of amalgamation between Dr. Agarwal's Eye Hospital Ltd and Dr. Agarwal's Health Care Ltd. The scheme will become effective from November 1, 2026, and the record date for allotment of consideration shares has been fixed as November 18, 2026.

Dr. Agarwals Health Care Ltd has fixed the record date for allotment of consideration shares to eligible shareholders of Dr. Agarwals Eye Hospital Ltd as Nov 18, 2026, as part of the scheme of amalgamation between the two companies.

Dr. Agarwal's Health Care Limited has announced the record date for the Scheme of Amalgamation with Dr. Agarwal's Eye Hospital Limited as November 18, 2026.

The Board of Directors of Dr. Agarwal's Health Care Limited has approved the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited, with the Scheme becoming effective from November 01, 2026. The authorized share capital of Dr. Agarwal's Eye Hospital Limited has been reclassified into 20,00,00,000 Equity Shares of face value of ₹1 each, and the entire re-classified authorized share capital of Dr. Agarwal's Eye Hospital Limited will be automatically combined and merged with the existing authorized share capital of Dr. Agarwal's Health Care Limited. The Record Date for determining the eligible equity shareholders of Dr. Agarwal's Eye Hospital Limited entitled to receive Consideration Shares has been fixed as Wednesday, November 18, 2026.

Dr. Agarwal's Health Care Ltd has announced the outcome of its Board Meeting held on October 20, 2026, in connection with a Material Update on the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited. The Board has noted, considered, and approved the effectiveness of the Scheme, alteration of the authorized share capital, and fixation of the record date for allotment of consideration shares to eligible shareholders.

Genomic Valley Biotech Ltd's promoter, Yogesh Agrawal, has entered into a Share Purchase Agreement with Pankaj Grover and Abhisek Gupta to sell their entire shareholding in the company. The transaction will result in the acquirers acquiring control over the company and will attract an obligation to make an open offer to public shareholders.

Avalon Technologies Limited has informed the Exchange regarding the incorporation of Zollner Avalon Private Limited, a wholly owned subsidiary.

REC Limited has received No Objection Letters from BSE Limited and National Stock Exchange of India Limited for the proposed scheme of merger with Power Finance Corporation Limited.

REC Ltd has received No Objection Letters from BSE and NSE for its proposed scheme of merger with Power Finance Corporation Ltd, subject to regulatory approvals and other conditions.

Power Finance Corporation Ltd has received No Objection letters from BSE and NSE for the proposed scheme of merger of REC Limited with and into Power Finance Corporation Limited, subject to regulatory and other approvals.

Power Finance Corporation Limited has received No Objection letters from BSE Limited and National Stock Exchange of India Limited for the proposed scheme of merger of REC Limited with Power Finance Corporation Limited.

GOCL Corporation Limited has informed the Exchange regarding Outcome of Board Meeting held on October 19, 2026 - Update on Scheme of Merger of HNPCL with GOCL. The Board approved and took on record the un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026. The Board also noted the Order dated October 08, 2026, passed by the Hon'ble National Company Law Tribunal, directing the convening of the meeting of the Equity Shareholders and Unsecured Creditors of the Company in connection with the proposed Scheme of Merger by Absorption of Hinduja National Power Corporation Limited with GOCL Corporation Limited.

Systematic Industries Limited has informed BSE about Intimation on Agreements.

Systematic Industries Ltd has entered into a Share Purchase Agreement with Veritas Industries Private Limited and Wire Brigade Industries Private Limited to acquire 100% of the equity shareholding of Wire Brigade Industries Private Limited for cash and share swap.

Soni Medicare Ltd has informed BSE that a meeting of the Board of Directors is scheduled on 26/10/2026 to consider a Healthcare Operations and Management (O&M) Framework Agreement with a vendor for Soni Hospital.

Quality Power Electrical Equipments Limited held an Extra Ordinary General Meeting on October 19, 2026, where the company discussed the proposed acquisition of Winwin Speciality Insulators Limited, a QIP for funding expansion plans, and promoter financing arrangements.

Quality Power Electrical Equipments Ltd held an Extra Ordinary General Meeting on October 19, 2026, through video conferencing. The meeting was attended by 35 members, and the company's chairman and managing director, Thalavaidurai Pandyan, briefed the shareholders on the proposed acquisition of Winwin Speciality Insulators Limited, a QIP for funding the company's expansion plans, and promoter financing arrangements.

Clio Infotech Ltd has approved an investment in Clio Quantinfra Limited, a UK-based company, which will become a subsidiary after the investment. The investment amount is approximately £1000, and the company will subscribe to 1000 equity shares. The trading window for dealing securities has been closed until 48 hours after the declaration of financial results for the quarter and half-year ended September 30, 2026.